The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. Introduction.
Handelsman
Yehuda
Y
D000499:Allylamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001647:Bile Acids and Salts / Q000378:metabolism; D001786:Blood Glucose / Q000187:drug effects*; D002487:Centers for Disease Control and Prevention, U.S.; D000069472:Colesevelam Hydrochloride; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D014481:United States
D000499:Allylamine; D000924:Anticholesteremic Agents; D001647:Bile Acids and Salts; D001786:Blood Glucose; D000069472:Colesevelam Hydrochloride; D006442:Glycated Hemoglobin